Delta Sleep Inducing Peptide Dsip Lyophilized Raw Materials Powder CAS 62568-57-4

  Product Detail  

• Delta (DSIP) is a linear nine-membered short peptide that acts as a stress-limiting factor and may have antioxidant effects. What's more, withdrawal symptoms from alcohol and opioid use can be treated with DSIP. It improves sleep efficiency and shortens sleep latency. DSIP is a potent analgesic in mice that reduces pain in migraine, vasomotor headache.

• 
  
• 
• 
  
• 
• 
  

• Delta (DSIP) is a neuropeptide found to regulate sleep, mood, and stress responses. As a bioactive substance, DSIP plays an important role in the neuroendocrine system.

• DSIP is described by the medical community as a sleep-promoting substance, not a sedative. It can have a modular effect on sleep and wake functions. The peptide had little effect on healthy subjects without sleep disorders.
• DSIP, short for Delta sleep-inducing peptide, is a naturally occurring peptide synthesized in the hypothalamus and other brain areas.
• 
  
• Product Specification:                                                   
• 
  

• Produsts Name	DSIP
  CAS No	62568-57-4
  Purity	>99%
  Appearance	White  powder
  storage	keep in a cool,dark location in a tightly sealed container or cylinder.
  Shelf Life	24 Months

  
  

  Company Profile                                                            

    Changsha Duole Technology Co., Ltd was established in 2020 with strong research and development capabilities and superb synthesis technology, as well as advanced quality control measures.

    With synthetic biology platform technology as the core, it conducts innovative research and development, mainly engaged in the research and development of recombinantly expressed pharmaceutical peptides and proteins. Its products include innovative drugs, APIs, pharmaceutical and green synthetic industrial enzymes, functional peptides and protein products, etc.

    Its core team is composed of technical experts in the fields of pharmaceutical engineering, fermentation engineering and protein engineering. The company has built a 3,300-square-meter recombinant drug research and development center in Shibei, Yuelu District, Changsha City. It has a complete pharmaceutical engineering, preparation and quality research system and talent team, and has built a GMP workshop to meet the international market API supply and CDMO services.

    At present, our company has realized the industrialization of a variety of biosynthetic peptide products and has obtained cooperation orders from many well-known domestic and foreign pharmaceutical companies.